Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Journal of the American Academy of Dermatology|October 28, 2021
Difamilast ointment in adult patients with atopic dermatitis: A phase 3 randomized, double-blind, vehicle-controlled trialHidehisa Saeki, Kensuke Ito, Daisuke Yokota, et al.
Dermatology and Therapy|June 18, 2022
Difamilast Ointment in Japanese Adult and Pediatric Patients with Atopic Dermatitis: A Phase III, Long-Term, Open-Label StudyHidehisa Saeki, Tomomi Imamura, Daisuke Yokota, et al.
Cureus|April 3, 2023
Endovascular Retrieval of a Fractured Tunneled Hemodialysis Central Venous Catheter Using the Loop Snare TechniqueTomoko Sasaki, Yuki Fujioka, Haruka Hikichi, et al.
Journal of Atherosclerosis and Thrombosis|March 2, 2025
Efficacy and Safety of Bempedoic Acid for Hypercholesterolemia in Japan: A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding TrialShizuya Yamashita, Hitomi Fujita, Daisuke Yokota, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 30, 2025
Efficacy and Safety of Bempedoic Acid in Japanese Patients With Hypercholesterolemia - A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study (the CLEAR-J Trial)Shizuya Yamashita, Arihiro Kiyosue, Hitomi Fujita, et al.
Genomics|June 4, 2016
Enhancer activity-based identification of functional enhancers using zebrafish embryosTomohito Taminato, Daisuke Yokota, Soh Araki, et al.
Dermatology and Therapy|October 31, 2025
A Phase 3, Long-Term, Open-Label Study of Difamilast Ointment to Evaluate Efficacy and Safety in Japanese Infants with Atopic DermatitisHidehisa Saeki, Yukihiro Ohya, Naoko Baba, et al.
Dermatology and Therapy|July 29, 2024
An Interim Report of a Phase 3, Long-Term, Open-Label Study to Evaluate Efficacy and Safety of Difamilast Ointment in Japanese Infants with Atopic DermatitisHidehisa Saeki, Yukihiro Ohya, Naoko Baba, et al.
Journal of Atherosclerosis and Thrombosis|November 30, 2025
Long-term Safety and Efficacy of Bempedoic Acid in Japanese Patients with Hypercholesterolemia: the CLEAR-J LONGDaisaku Masuda, Kouji Kajinami, Nobutaka Sakayoshi, et al.
The Journal of Biological Chemistry|December 24, 2009
Reduction of Raf kinase inhibitor protein expression by Bcr-Abl contributes to chronic myelogenous leukemia proliferationTomonari Takemura, Satoki Nakamura, Daisuke Yokota, et al.
Pageof 4